Title:
NANO-MOLECULE AGGREGATE CONSISTING OF ORGANIC MATERIAL, INORGANIC MATERIAL OR SALT THEREOF AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2023/063796
Kind Code:
A1
Abstract:
The present invention relates to a pharmacologically active ingredient-derived molecule aggregate prepared by applying shear stress to a solution including a pharmacologically active ingredient.
Inventors:
KIM CHUL HWAN (KR)
KIM KYOUNG HEE (KR)
KIM KYOUNG HEE (KR)
Application Number:
PCT/KR2022/015656
Publication Date:
April 20, 2023
Filing Date:
October 14, 2022
Export Citation:
Assignee:
SCAI THERAPEUTICS CO LTD (KR)
International Classes:
A61K9/14
Foreign References:
| KR20060070212A | 2006-06-23 | |||
| KR20200006602A | 2020-01-20 | |||
| JP2002507976A | 2002-03-12 | |||
| KR20110053775A | 2011-05-24 |
Other References:
TRASI NIRAJ S., PUROHIT HITESH S., WEN HONG, SUN DAJUN D., TAYLOR LYNNE S.: "Non-sink dissolution behavior and solubility limit of commercial tacrolimus amorphous formulations", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 106, no. 1, 1 January 2017 (2017-01-01), US , pages 264 - 272, XP009545300, ISSN: 0022-3549, DOI: 10.1016/j.xphs.2016.09.016
BABU N. JAGADEESH, NANGIA ASHWINI: "Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals", CRYSTAL GROWTH & DESIGN, ASC WASHINGTON DC, US, vol. 11, no. 7, 6 July 2011 (2011-07-06), US , pages 2662 - 2679, XP055827847, ISSN: 1528-7483, DOI: 10.1021/cg200492w
BABU N. JAGADEESH, NANGIA ASHWINI: "Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals", CRYSTAL GROWTH & DESIGN, ASC WASHINGTON DC, US, vol. 11, no. 7, 6 July 2011 (2011-07-06), US , pages 2662 - 2679, XP055827847, ISSN: 1528-7483, DOI: 10.1021/cg200492w
Attorney, Agent or Firm:
KIM, Sung Ho (KR)
Download PDF: